Neurogene and Neoleukin announce definitive merger agreement
Upon completion of the merger, which is subject to approval by Neurogene and Neoleukin stockholders, the combined company is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
genetic medicine
Eli Lilly announces Institute for Genetic Medicine and $700 million investment in Boston Seaport…
The facility will headquarter research efforts in Boston and New York to accelerate the development of RNA and DNA-based medicines